DMAA

Drugs Made In America Acquisition Corp. Ordinary Shares

10.26 USD
-0.01
0.10%
At close Aug 26, 4:00 PM EDT
1 day
-0.10%
5 days
0.00%
1 month
-0.10%
3 months
1.38%
6 months
2.91%
Year to date
3.01%
1 year
3.01%
5 years
3.01%
10 years
3.01%
 

About: Drugs Made In America Acquisition Corp is a blank check company.

0
Funds holding %
of 7,433 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

33% more funds holding

Funds holding: 24 [Q1] → 32 (+8) [Q2]

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

24% more capital invested

Capital invested by funds: $171M [Q1] → $212M (+$41M) [Q2]

3.34% more ownership

Funds ownership: 58.79% [Q1] → 62.13% (+3.34%) [Q2]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q1] → 1 (-1) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for DMAA.

Financial journalist opinion

We haven’t received any recent news articles for DMAA.

Charts implemented using Lightweight Charts™